Note: Ingredients listed on restricted chemical lists
EC/CAS
18472-51-0
Name of the chemical
D-Gluconic acid, compound with N,N′′-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine(2:1)
Concentration
<100
General Information
Version
3.0
Revision date
2026-01-20
Product name
Extractant
1.2.2. Uses advised against
Do not use kit components from one kit with any other kit
supplier name
Neogen Corporation
Emergency telephone
1-800-498-5743, 1-651-523-0318, 1-800-424-9300, 1-703-527-3887
Icons in SDS
Company Information
company name
Neogen Corporation
e-mail address of the competent person responsible for the Safety Data Sheet
sds@neogen.com, naa@neogen.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H319, H412
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Classification of the hazardous chemical Classification according to the Environmental Protection Authority notices (EPA Hazardous Substances and New Organisms Act 1996) Serious eye damage/eye irritation, Category 2 H319 Skin sensitisation, Category 1 H317 Hazardous to the aquatic environment – Chronic Hazard, Category 3 H412
2.2 Label elements
GHS NZ labelling
Hazard pictograms
(GHS NZ)
Signal word
Warning
Contains
Chlorhexidine Digluconate 20% Solution (< 100 %); Deviron® 13-S9 (> 1.516 %); 1- Piperazineethanesulfonic acid, 4-(2-hydroxyethyl)-, monosodium salt (< 100 %)
Hazard statements
(GHS NZ) : H317 - May cause an allergic skin reaction H319 - Causes serious eye irritation H412 - Harmful to aquatic life with long lasting effects
Prevention
P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P272 - Contaminated work clothing should not be allowed out of the workplace. P273 - Avoid release to the environment. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection.
Response
P302+P352 - IF ON SKIN: Wash with plenty of water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P321 - Specific treatment (see supplemental first aid instruction on this label). P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P337+P313 - If eye irritation persists: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse.
Disposal
P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
Other hazards which do not result in classification
No additional information available
2.1 Classification of the substance or mixture
Classification according to the Environmental Protection Authority notices (EPA Hazardous Substances and New Organisms Act 1996) Serious eye damage/eye irritation, Category 2 H319 Skin sensitisation, Category 1 H317 Hazardous to the aquatic environment – Chronic Hazard, Category 3 H412 2.2. GHS Label elements, including precautionary statements GHS NZ labelling Hazard pictograms (GHS NZ) : Signal word (GHS NZ) : Warning Contains : Chlorhexidine Digluconate 20% Solution (< 100 %); Deviron® 13-S9 (> 1.516 %); 1- Piperazineethanesulfonic acid, 4-(2-hydroxyethyl)-, monosodium salt (< 100 %) Hazard statements (GHS NZ) : H317 - May cause an allergic skin reaction H319 - Causes serious eye irritation H412 - Harmful to aquatic life with long lasting effects Prevention : P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P272 - Contaminated work clothing should not be allowed out of the workplace. P273 - Avoid release to the environment. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. Response : P302+P352 - IF ON SKIN: Wash with plenty of water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P321 - Specific treatment (see supplemental first aid instruction on this label). P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P337+P313 - If eye irritation persists: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse. Disposal : P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation. 2.3. Other hazards which do not result in classification No additional information available SECTION 3: Composition and information on ingredients 3.1. Substances Not applicable 3.2. Mixtures Name Product identifier % Classification according to GHS NZ Chlorhexidine Digluconate 20% Solution CAS-No.: 18472-51-0 < 100 Aquatic Chronic 2, H411 Deviron® 13-S9 CAS-No.: 68131-40-8 > 1.516 Acute Tox. 4 (Oral), H302 Skin Irrit. 2, H315 Eye Dam. 1, H318 Aquatic Chronic 2, H411 1-Piperazineethanesulfonic acid, 4-(2-hydroxyethyl)-, CAS-No.: 75277-39-3 < 100 Skin Sens. 1, H317 monosodium salt SECTION 4: First-aid measures 4.1. Description of necessary first-aid measures First-aid measures general : If you feel unwell, seek medical advice. First-aid measures after inhalation : Remove person to fresh air and keep comfortable for breathing. First-aid measures after skin contact : Wash skin with plenty of water. Take off contaminated clothing. If skin irritation or rash occurs: Get medical advice/attention. First-aid measures after eye contact : Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention. First-aid measures after ingestion : Call a poison center or a doctor if you feel unwell. Self protection of the first-aider : First-aiders should pay attention to their own protection and use the recommended personal protective equipment (see section 8). 4.2. Symptoms caused by exposure Symptoms/effects after inhalation : None under normal conditions. Symptoms/effects after skin contact : May cause an allergic skin reaction. Symptoms/effects after eye contact : Eye irritation. Symptoms/effects after ingestion : None under normal conditions.